Daniel Calkins compensation by year
Verastem Summary Compensation Table · all 4 fiscal years held| Component | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Salary | $221,731 | $257,529 | $325,000 | $350,000 |
| Bonus | $0 | $0 | $0 | $0 |
| Stock awards | $30,601 | $0 | $254,079 | $450,721 |
| Option awards | $34,279 | $220,731 | $15,241 | $0 |
| Non-equity incentive | $72,900 | $126,000 | $124,000 | $151,200 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $16,036 | $18,304 | $22,690 | $24,950 |
| Total | $375,547 | $622,564 | $741,010 | $976,871 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Verastem, Inc. DEF 14A filed April 9, 2026, accession 0001104659-26-041506, and prior-year filings.
How this page was built: the Verastem, Inc. filed document, accession 0001104659-26-041506. Every figure is read from that document and cited to the page and table it appears in. Filed April 9, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 38,800 | $299,536 | — |
| RSU | 25,900 | $199,948 | — |
| PSU | 25,866 | $199,686 | — |
| RSU | 546 | $4,215 | — |
| Option | 12,500 | — | $6.89 |
| Option | 4,295 | — | $7.97 |
| Option | 820 | — | $10.50 |
| Option | 663 | — | $11.44 |
| Option | 2,709 | — | $11.44 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Verastem, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Verastem’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Daniel Paterson | President and Chief Executive Officer | $2,349,975 |
| Matthew Ros | Former Chief Operating Officer | $1,625,163 |
| Daniel Calkins · this page | Chief Financial Officer | $976,871 |
| Michael Kauffman | President of Development | $272,993 |
Daniel Calkins's compensation dossier, Verastem
You have read Daniel Calkins's totals and holdings. The dossier adds each equity grant Verastem disclosed for Daniel Calkins and Verastem's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full Verastem compensation record
free company briefThis page is one person within Verastem's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Verastem proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Verastem's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Verastem's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.